These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38273693)

  • 1. Comparison of the correlation between serum autoantibodies against aldehyde dehydrogenase 2 and thyrotropin receptor in patients with Graves' ophthalmopathy.
    Lin CC; Chiu LW; Lee PY; Chen KJ; Cheng KC
    Indian J Ophthalmol; 2024 Feb; 72(2):298-299. PubMed ID: 38273693
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves' Orbitopathy.
    George A; Diana T; Längericht J; Kahaly GJ
    Front Endocrinol (Lausanne); 2020; 11():629925. PubMed ID: 33603715
    [No Abstract]   [Full Text] [Related]  

  • 3. Euthyroid Graves' ophthalmopathy with negative autoantibodies.
    Cakir M
    J Natl Med Assoc; 2005 Nov; 97(11):1547-9. PubMed ID: 16334503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Rinsho; 2006 May; Suppl 1():307-10. PubMed ID: 16776151
    [No Abstract]   [Full Text] [Related]  

  • 5. Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy.
    Ryder M; Wentworth M; Algeciras-Schimnich A; Morris JC; Garrity J; Sanders J; Young S; Sanders P; Furmaniak J; Rees Smith B
    Thyroid; 2021 Oct; 31(10):1597-1602. PubMed ID: 34114495
    [No Abstract]   [Full Text] [Related]  

  • 6. Unilateral optic neuropathy as the initial manifestation of euthyroid Graves' disease.
    Arslan E; Yavaşoğlu I; Cildağ BM; Kocatürk T
    Intern Med; 2009; 48(22):1993-4. PubMed ID: 19915303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.
    Shibayama K; Ohyama Y; Yokota Y; Ohtsu S; Takubo N; Matsuura N
    Endocr J; 2005 Oct; 52(5):505-10. PubMed ID: 16284425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis.
    Silva de Morais N; Angell TE; Ahmadi S; Alexander EK; Dos Santos Teixeira PF; Marqusee E
    Endocr Pract; 2022 May; 28(5):502-508. PubMed ID: 35091101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
    Nicolì F; Lanzolla G; Mantuano M; Ionni I; Mazzi B; Leo M; Sframeli A; Posarelli C; Maglionico MN; Figus M; Nardi M; Marcocci C; Marinò M
    J Endocrinol Invest; 2021 Mar; 44(3):581-585. PubMed ID: 32648002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-Stimulating Antibody/Thyroid-Stimulating Hormone Receptor Antibody Ratio as a Sensitive Screening Test for Active Graves' Orbitopathy.
    Nakano M; Konishi H; Koshiba M
    Endocr Pract; 2022 Oct; 28(10):1050-1054. PubMed ID: 35870804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Retinal Microvascular Density Related to Activity Status and Serum Antibodies in Patients with Graves' Ophthalmopathy.
    Wu Y; Tu Y; Bao L; Wu C; Zheng J; Wang J; Lu F; Shen M; Chen Q
    Curr Eye Res; 2020 May; 45(5):576-584. PubMed ID: 31595798
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
    Khoo TK; Bahn RS
    Thyroid; 2007 Oct; 17(10):1013-8. PubMed ID: 17935483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
    Woo YJ; Jang SY; Lim TH; Yoon JS
    Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSH receptor specific monoclonal autoantibody K1-70
    Furmaniak J; Sanders J; Sanders P; Li Y; Rees Smith B
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):878-887. PubMed ID: 35088429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.
    Nielsen CH; El Fassi D; Hasselbalch HC; Bendtzen K; Hegedüs L
    Expert Opin Biol Ther; 2007 Jul; 7(7):1061-78. PubMed ID: 17665994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.